FDA
approval
· 2011-12-07
FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
Summary
The FDA approved a supplemental application for Exforge HCT (amlodipine/valsartan/hydrochlorothiazide) submitted by Novartis Pharmaceuticals Corporation. The ap…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EXFORGE HCT (AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE)